Skip to main content
. Author manuscript; available in PMC: 2014 Apr 14.
Published in final edited form as: J Med Chem. 2013 Aug 21;56(17):6803–6818. doi: 10.1021/jm400619b

Figure 1.

Figure 1

Structures of various Hsp90 inhibitors and the chemotypes they belong to. All but geldanamycin have been or currently are in clinical evaluation for cancers.